Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

8.480 +0.210 (+2.54%)
Streaming Delayed Price Updated: 3:13 PM EST, Feb 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Moss, Microbes, and the Martian Dream: How Tiny Organisms Are Paving the Way for Off-World Colonies
The ambitious dream of humanity establishing permanent settlements beyond Earth is taking a significant leap forward, not through advanced robotics or colossal spacecraft, but with the humble power of... 
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus ↗
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial results. 
Via Benzinga
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings ↗
 
Via Benzinga
News headline image
AI Unlocks Secrets of Intrinsically Disordered Proteins: A Paradigm Shift in Biomedical Design
A groundbreaking advancement in artificial intelligence has opened new frontiers in understanding and designing intrinsically disordered proteins (IDPs), a class of biomolecules previously considered... 
Via TokenRing AI
Topics Artificial Intelligence Derivatives
News headline image
5 Healthcare Stocks On Fire This Week ↗
Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech & pharma. 
Via Benzinga
News headline image
Ginkgo Bioworks Holdings Inc (NYSE:DNA) Fits the Minervini Trend Template with Strong Technicals and High-Growth Momentum ↗
Ginkgo Bioworks (DNA) meets Minervini Trend Template criteria with strong technicals, earnings growth, and momentum, making it a high-growth stock to watch. 
Via Chartmill
News headline image
From Promise to Peril: The Downfall of Ginkgo Bioworks ↗
 
Via Benzinga
News headline image
Hewlett Packard Enterprise, Magnite, GMS And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing ↗
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods. 
Via Benzinga
Topics Animal Testing
News headline image
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expert ↗
U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading. 
Via Benzinga
Topics Stocks
News headline image
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
What's Going On With Ginkgo Bioworks Stock This Week? ↗
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on. 
Via Benzinga
News headline image
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today ↗
The company is forging ahead with next-generation drug development solutions. 
Via The Motley Fool
News headline image
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development ↗
Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery by leveraging AI and proprietary biological data, offering affordable and... 
Via Benzinga
Topics Artificial Intelligence
News headline image
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why ↗
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud. 
Via Benzinga
News headline image
Compass Minerals, Torrid Holdings, Icahn Enterprises, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors? ↗
Could this beaten-down stock turn things around in the near future? 
Via The Motley Fool
News headline image
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock ↗
The risks may resolve in a year or so but seizing the opportunities will take longer. 
Via The Motley Fool
News headline image
This 1 AI Stock Could Revolutionize Biotech and Pharma ↗
The company is using artificial intelligence, and planning to help others use AI empowered by its data collection. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock? ↗
Its ambitious business model may not be sustainable. 
Via The Motley Fool
News headline image
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now? ↗
Have shares of the troubled life sciences business fallen too far? 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.